Bayzed Health maintains 1.32 billion issued shares and meets public-float rule in July 2026 disclosure

Bulletin Express08-05

Bayzed Health Group Inc filed its Monthly Return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming that both authorised and issued share capital remained unchanged during the month.

Authorised capital stood at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000.

Issued share capital closed the month at 1.32 billion ordinary shares. The company held no treasury shares, and no share movements—issuances, cancellations or repurchases—were recorded in July.

The post-IPO share-option scheme adopted on 8 August 2023 showed zero outstanding options and no share issuances, leaving no shares available or pending under the scheme. No warrants, convertible instruments or other share-issuing arrangements were outstanding.

Bayzed Health confirmed compliance with the Main Board’s minimum public-float requirement of 25% as at 31 July 2026.

Executive Director Chen Haoyang certified that all disclosures comply with Hong Kong listing rules and relevant legal obligations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181565241?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 16:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181565241","market":"us","top_or_hot":-1,"title":"Bayzed Health maintains 1.32 billion issued shares and meets public-float rule in July 2026 disclosure","media":"Bulletin Express","content":"<p>Bayzed Health Group Inc filed its Monthly Return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming that both authorised and issued share capital remained unchanged during the month.</p>\n<p>Authorised capital stood at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000.</p>\n<p>Issued share capital closed the month at 1.32 billion ordinary shares. The company held no treasury shares, and no share movements—issuances, cancellations or repurchases—were recorded in July.</p>\n<p>The post-IPO share-option scheme adopted on 8 August 2023 showed zero outstanding options and no share issuances, leaving no shares available or pending under the scheme. No warrants, convertible instruments or other share-issuing arrangements were outstanding.</p>\n<p>Bayzed Health confirmed compliance with the Main Board’s minimum public-float requirement of 25% as at 31 July 2026.</p>\n<p>Executive Director Chen Haoyang certified that all disclosures comply with Hong Kong listing rules and relevant legal obligations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayzed Health maintains 1.32 billion issued shares and meets public-float rule in July 2026 disclosure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayzed Health maintains 1.32 billion issued shares and meets public-float rule in July 2026 disclosure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 16:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bayzed Health Group Inc filed its Monthly Return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming that both authorised and issued share capital remained unchanged during the month.</p>\n<p>Authorised capital stood at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000.</p>\n<p>Issued share capital closed the month at 1.32 billion ordinary shares. The company held no treasury shares, and no share movements—issuances, cancellations or repurchases—were recorded in July.</p>\n<p>The post-IPO share-option scheme adopted on 8 August 2023 showed zero outstanding options and no share issuances, leaving no shares available or pending under the scheme. No warrants, convertible instruments or other share-issuing arrangements were outstanding.</p>\n<p>Bayzed Health confirmed compliance with the Main Board’s minimum public-float requirement of 25% as at 31 July 2026.</p>\n<p>Executive Director Chen Haoyang certified that all disclosures comply with Hong Kong listing rules and relevant legal obligations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02609","symbol_name":"佰泽医疗","start_time":0,"source_url":"","article_id":"1181565241","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181565241","pubTimestamp":1785919755,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Bayzed Health Group Inc filed its Monthly Return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming that both authorised and issued share capital remained...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02609":"佰泽医疗"},"translate_title":"Bayzed Health 持有 13.2 亿股已发行股份，并于 2026 年 7 月符合公开发行规则","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02609":1},"content_text":"Bayzed Health Group Inc filed its Monthly Return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, confirming that both authorised and issued share capital remained unchanged during the month.\nAuthorised capital stood at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000.\nIssued share capital closed the month at 1.32 billion ordinary shares. The company held no treasury shares, and no share movements—issuances, cancellations or repurchases—were recorded in July.\nThe post-IPO share-option scheme adopted on 8 August 2023 showed zero outstanding options and no share issuances, leaving no shares available or pending under the scheme. No warrants, convertible instruments or other share-issuing arrangements were outstanding.\nBayzed Health confirmed compliance with the Main Board’s minimum public-float requirement of 25% as at 31 July 2026.\nExecutive Director Chen Haoyang certified that all disclosures comply with Hong Kong listing rules and relevant legal obligations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181565241","isCrawlerRequest":true}